These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Burden of depression and anxiety among patients with inflammatory bowel disease: results of a nationwide analysis. Tarar ZI; Zafar MU; Farooq U; Ghous G; Aslam A; Inayat F; Ghouri YA Int J Colorectal Dis; 2022 Feb; 37(2):313-321. PubMed ID: 34731298 [TBL] [Abstract][Full Text] [Related]
27. Prevalence and effectiveness of psychiatric treatments for patients with IBD: A systematic literature review. Tarricone I; Regazzi MG; Bonucci G; Rizzello F; Carini G; Muratori R; Poggioli G; Campieri M; J Psychosom Res; 2017 Oct; 101():68-95. PubMed ID: 28867427 [TBL] [Abstract][Full Text] [Related]
28. Comparison of comorbid depression between irritable bowel syndrome and inflammatory bowel disease: A meta-analysis of comparative studies. Geng Q; Zhang QE; Wang F; Zheng W; Ng CH; Ungvari GS; Wang G; Xiang YT J Affect Disord; 2018 Sep; 237():37-46. PubMed ID: 29758449 [TBL] [Abstract][Full Text] [Related]
29. Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: The IBSEN study. Huppertz-Hauss G; Høivik ML; Jelsness-Jørgensen LP; Opheim R; Henriksen M; Høie O; Hovde Ø; Kempski-Monstad I; Solberg IC; Jahnsen J; Hoff G; Moum B; Bernklev T Scand J Gastroenterol; 2017 Mar; 52(3):351-358. PubMed ID: 27852169 [TBL] [Abstract][Full Text] [Related]
30. Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysis. Gracie DJ; Irvine AJ; Sood R; Mikocka-Walus A; Hamlin PJ; Ford AC Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):189-199. PubMed ID: 28404134 [TBL] [Abstract][Full Text] [Related]
31. Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease. Fiest KM; Bernstein CN; Walker JR; Graff LA; Hitchon CA; Peschken CA; Zarychanski R; Abou-Setta A; Patten SB; Sareen J; Bolton J; Singer A; Marrie RA; BMC Res Notes; 2016 Aug; 9(1):404. PubMed ID: 27514366 [TBL] [Abstract][Full Text] [Related]
32. Psychological disorders and coping strategies in patients with inflammatory bowel disease. Their impact on health-related quality of life. Jara Fernández L; Ferrer JÁ; Pérez Calle JL; Martínez Álvarez L; López Serrano P Rev Esp Enferm Dig; 2024 Apr; 116(4):193-200. PubMed ID: 37982549 [TBL] [Abstract][Full Text] [Related]
33. A Comparison of the Prevalence of Anxiety and Depression Between Uncomplicated and Complex IBD Patient Groups. Yongwen Ng J; Chauhan U; Armstrong D; Marshall J; Tse F; Moayyedi P; Reinisch W; Halder S Gastroenterol Nurs; 2018; 41(5):427-435. PubMed ID: 30272605 [TBL] [Abstract][Full Text] [Related]
34. The bidirectional risk of inflammatory bowel disease and anxiety or depression: A systematic review and meta-analysis. Bisgaard TH; Allin KH; Elmahdi R; Jess T Gen Hosp Psychiatry; 2023; 83():109-116. PubMed ID: 37172544 [TBL] [Abstract][Full Text] [Related]
35. Robust Association Between Inflammatory Bowel Disease and Generalized Anxiety Disorder: Findings from a Nationally Representative Canadian Study. Fuller-Thomson E; Lateef R; Sulman J Inflamm Bowel Dis; 2015 Oct; 21(10):2341-8. PubMed ID: 26218145 [TBL] [Abstract][Full Text] [Related]
36. Systematic review: psychological morbidity in young people with inflammatory bowel disease - risk factors and impacts. Brooks AJ; Rowse G; Ryder A; Peach EJ; Corfe BM; Lobo AJ Aliment Pharmacol Ther; 2016 Jul; 44(1):3-15. PubMed ID: 27145394 [TBL] [Abstract][Full Text] [Related]
37. The prevalence and risk factors of psychological disorders, malnutrition and quality of life in IBD patients. Cao Q; Huang YH; Jiang M; Dai C Scand J Gastroenterol; 2019 Dec; 54(12):1458-1466. PubMed ID: 31791216 [No Abstract] [Full Text] [Related]
38. Effectiveness of cognitive-behavioral therapy on quality of life, anxiety, and depressive symptoms among patients with inflammatory bowel disease: A multicenter randomized controlled trial. Bennebroek Evertsz' F; Sprangers MAG; Sitnikova K; Stokkers PCF; Ponsioen CY; Bartelsman JFWM; van Bodegraven AA; Fischer S; Depla ACTM; Mallant RC; Sanderman R; Burger H; Bockting CLH J Consult Clin Psychol; 2017 Sep; 85(9):918-925. PubMed ID: 28857595 [TBL] [Abstract][Full Text] [Related]
39. Depression and anxiety are associated with poor outcomes in patients with inflammatory bowel disease: A nationwide population-based cohort study in South Korea. Kim S; Lee S; Han K; Koh SJ; Im JP; Kim JS; Lee HJ Gen Hosp Psychiatry; 2023; 81():68-75. PubMed ID: 36827815 [TBL] [Abstract][Full Text] [Related]
40. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners. Abdalla MI; Sandler RS; Kappelman MD; Martin CF; Chen W; Anton K; Long MD Inflamm Bowel Dis; 2017 Feb; 23(2):325-331. PubMed ID: 28092305 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]